• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Milken Institute's Sarah Wells Kocsis on How Climate Change, Aging Impact CKD Care

Video

Sarah Wells Kocsis, MBA, is co-author of the Milken Institute report, “Chronic Kidney Disease: Finding a Path to Prevention, Earlier Detection, and Management.” She spoke to The American Journal of Managed Care® about the findings of the report and how they can be incorporated into care for patients with chronic kidney disease (CKD).

Sarah Wells Kocsis, MBA, director of the Center for Public Health at the Milken Institute, talks about the implications of climate change and aging patients on chronic kidney disease (CKD) care in her recently authored report, “Chronic Kidney Disease: Finding a Path to Prevention, Earlier Detection, and Management.”

Transcript

What are the biggest implications of climate change and the aging population on CKD care?

Another very thoughtful question. Climate change and our increasing aging population are really what's going to define the future of health. And both of them are obviously having [an] impact [on] and implications for everyone in society and on the planet, but there are some certain groups and their health that are impacted more than others. Increasingly susceptible to CKD are outdoor laborers, such as agricultural workers. And then among our seniors, there's a cohort of seniors that are living in isolation, they're living in poverty, and they're struggling with food insecurity. These subset populations are particularly at risk when we're talking about the impact of climate change and aging.

When we were doing this report, we worked with thought leaders who are experts in the space and one of them made a comment that really resonated with our team. That was that CKD is really a mirror of many of the things that are so wrong with our health care system. So I think that when you step back and reflect on that, it really sums up what a growing public health threat we're facing, both at the societal level with those big changes you mentioned, but also the fact that there's just so many health equity gaps that are making CKD also a humanitarian crisis as well.

And so, the report that we wrote, really brings heightened awareness around CKD and it's really trying to call to action all members across the community to come together to respond.

Related Videos
Chesahna Kindred, MD, MBA, FAAD, board-certified dermatologist, Kindred Hair & Skin Center.
Debra Boyer, MD, MHPE, ATSF.
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Plasminogen is vital in the body's coagulation process and breaking down clots | image credit: peterschreiber.media - stock.adobe.com
ISPOR 2024 Recap
Chris Pagnani, MD, PC
Screenshot of Stephen Freedland, MD, during a video interview
Phaedra Corso, PhD, associate vice president for research at Indiana University
Julie Patterson, PharmD, PhD
William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.